Combined Sclc Recognised by Immunohistochemistry Will Not Exclude Patients from Molecular Treatment
AuthID
P-00R-2Q3
P-00R-2Q3
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service